Automated stem cell manufacturing: the experience at an academic center
Manufacturing clinically relevant quantities of mesenchymal stem cells brings about many challenges. The introduction of automation into the MSC manufacturing workflow ensures increased consistency and reproducibility, enhanced cell yield, and reduced cost and variability.
This webinar was recorded on 1 March 2022.
What will you learn?
- Challenges in MSC manufacturing in the cell therapy lab
- The role of automation in overcoming these challenges
Who may this interest?
- Cell therapy lab managers and scientists
- Manufacturing leads
- Process development/manufacturing engineers
Speaker
Nisha C. Durand PhD
Principal Research Technologist
Mayo Clinic (FL, USA)
Nisha Durand is currently the Principal Research Technologist and Operations Manager at the Human Cellular Therapy Lab – Center for Regenerative Medicine at Mayo Clinic Florida. At the Center for Regenerative Medicine, Dr. Durand is responsible for translating research processes into the cGMP environment and developing processes and techniques in support of all phases of cellular product development.
In association with
